HealthTree Foundation for Multiple Myeloma, Panobinostat (Farydak) Treatment Details
[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account
arrow_back Targeted Inhibitors
Panobinostat (Farydak)
Administration: oral
Information provided by www.dynamed.com and www.uptodate.com
newsletter icon

Stay Informed. Get the Support You Need for Multiple Myeloma.

By subscribing to the Healthtree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Genentech
Regeneron
Adaptive

Follow Us

facebook instagram linkedin tiktok youtube

Education

News Articles Patient Guides My Journal University Expert Webinars Find a Specialist HealthTree Podcast

Community

Connect Chapters Coach Moves All Events Community Support Groups Black Myeloma Health Resources in Spanish

Cure Hub

HealthTree Cure Hub Find Side Effects Solutions See Tracked Labs Connect Medical Records Treatment Options Twin Machine Clinical Trial Finder

Get Involved

Join a Regional Cure Team Create a fundraiser Tribute Donate Patient Surveys & Studies Connect Medical Records All Publications HealthTree Research Initiative

About us

Our Story HealthTree in The News Annual Reports

Need Help?

Contact Us FAQ & Help Center 1-800-709-1113

Legal Info

Terms of Use Privacy Policy

Charity Navigator https://www.guidestar.org/profile/45-5354811

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2025 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811